Friedrich Finckenstein
Chief Tech/Sci/R&D Officer presso IOVANCE BIOTHERAPEUTICS, INC.
Patrimonio netto: 630 769 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Friedrich Finckenstein
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 26 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Friedrich Finckenstein tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
Siliconix, Inc.
 Siliconix, Inc. SemiconductorsElectronic Technology Siliconix, Inc. manufactures semiconductors and switches. Its products are used to manage and convert power in computers, cell phones, and the communications infrastructure. The company also controls motion in computer disk drives and automotive systems. Siliconix was founded in 1962 and is headquartered in Santa Clara, CA. | Semiconductors | Director of Finance/CFO | |
| GENERAL MAGIC, INC. | Information Technology Services | Comptroller/Controller/Auditor | |
Goldman Sachs International
 Goldman Sachs International Financial ConglomeratesFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Financial Conglomerates | Analyst-Equity | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Personify, Inc. (California)
 Personify, Inc. (California) Packaged SoftwareTechnology Services Personify, Inc. manufactures e-Business analytics software. The firm operates as a Windows desktop application which works with webcam vedio chat apps such as Skype, Webex, Zoom, Hangouts and broadcast apps such OBS and XSplit. It develops Teleporter for AR/VR Holographic Live Streaming. The company was founded by Sanjay Jeram Patel in March 1996 and is headquartered in Menlo Park, CA. | Packaged Software | Director of Finance/CFO | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| TRAWS PHARMA, INC. | Biotechnology | Chairman | |
| CARA THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| University of Virginia | College/University | Undergraduate Degree | |
| University of Bath | College/University | Undergraduate Degree | |
| University of Oxford | College/University | Doctorate Degree | |
| George Washington University | College/University | Graduate Degree Graduate Degree | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Leeds | College/University | Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Santa Clara University | College/University | Undergraduate Degree Masters Business Admin | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Moscow Institute of Physics & Technology | College/University | Undergraduate Degree | |
| Glaxo, Inc. | Corporate Officer/Principal | ||
| Androclus Therapeutics, Inc. | Chief Executive Officer | ||
BITOECH Consulting SAS
 BITOECH Consulting SAS Miscellaneous Commercial ServicesCommercial Services Part of Mabion SA, Biotech Consulting is a French company that provides business consulting services. The private company is based in Cornier, France. | Miscellaneous Commercial Services | President | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree | |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Chairman Chief Operating Officer | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor | |
| IGNYTA INC | Biotechnology | Corporate Officer/Principal | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Angiex, Inc.
 Angiex, Inc. Miscellaneous Commercial ServicesCommercial Services Angiex, Inc. operates as a biotechnology company, which engages in the development of an antibody-drug conjugate therapy for cancer. It focuses on TM4SF1, a membrane glycoprotein of tetraspanin topology that was originally discovered as a protein expressed on many human epithelial tumor cells. The company was founded by Paul Jaminet, Harold Dvorak, and Shou-Ching Jaminet in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
LetsGetChecked, Inc.
 LetsGetChecked, Inc. Medical SpecialtiesHealth Technology LetsGetChecked, Inc. operates online platform which connects customers and diagnostic laboratories. It offers its diagnostics services for general health, sexual health, cancer screening and fertility and hormone check. The company was founded by Peter Foley in 2014 and is headquartered in Dun Laoghaire, Ireland. | Medical Specialties | Director of Finance/CFO | |
Arrys Therapeutics, Inc.
 Arrys Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Part of Ikena Oncology, Inc., Arrys Therapeutics, Inc. provides treatments to cancer patients. The private company is based in Boston, MA. The CEO of the company is Iain David Dukes. | Hospital/Nursing Management | Chief Executive Officer | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Founder Founder Director/Board Member | |
| TARSUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Viriom, Inc.
 Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Viriom, Inc. is a biotechnology company based in San Diego, CA. The company focuses on developing innovative therapies for infectious diseases, including HIV and COVID-19. Viriom's mission is to improve the lives of patients by providing effective and accessible treatments. Iain David Dukes has been the CEO of the company since 2019, leading the team in their efforts to advance the development of their pipeline and bring new therapies to market. | Miscellaneous Commercial Services | Chief Executive Officer | |
Paulus (Holdings) Ltd.
 Paulus (Holdings) Ltd. Financial ConglomeratesFinance Paulus (Holdings) Ltd. operates as a British investment company. | Financial Conglomerates | Director of Finance/CFO | |
Gwynant Therapeutics
 Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member | |
| CARGO THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
Trawsfynydd Therapeutics, Inc.
 Trawsfynydd Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trawsfynydd Therapeutics, Inc. engages in discovering and developing antiviral medicines. The company is located in the US. | Miscellaneous Commercial Services | Founder | |
Eilean Therapeutics LLC
 Eilean Therapeutics LLC Pharmaceuticals: MajorHealth Technology Eilean Therapeutics LLC is a biopharmaceutical company based in Dover, DE. Eilean Therapeutics is focused on the discovery and development of first-in-class small molecule inhibitors that target escape mutations in hematologic and solid cancers. Eilean Therapeutics LLC is utilizing a proprietary hybrid AI platform to accelerate the execution of discovery and development of novel breakthrough medicines to maximize the clinical benefit when treating hematologic and solid malignancies. The company was founded in 2022 by John C. Byrd and is co-founded by OrbiMed, Torrey Pines Investment. | Pharmaceuticals: Major | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 40 |
| Regno Unito | 6 |
| Canada | 3 |
| Russia | 2 |
| Israele | 2 |
Settori
| Health Technology | 27 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Technology Services | 4 |
| Finance | 4 |
Posizioni
| Director/Board Member | 108 |
| Independent Dir/Board Member | 46 |
| Corporate Officer/Principal | 42 |
| Director of Finance/CFO | 22 |
| Undergraduate Degree | 22 |
Contatti più connessi
| Insiders | |
|---|---|
| Merrill McPeak | 38 |
| Iain Dukes | 30 |
| Michael Weiser | 26 |
| Wendy Dixon | 25 |
| Timothy Morris | 21 |
| Wendy Yarno | 19 |
| Athena Countouriotis | 17 |
| Maria Fardis | 15 |
| Igor Bilinsky | 11 |
| Ryan Maynard | 10 |
| Jim Ziegler | 9 |
| Raymond Stapleton | 9 |
| Corinne Epperly | 8 |
| Wayne P. Rothbaum | 7 |
| Debora Barton | 7 |
- Borsa valori
- Insiders
- Friedrich Finckenstein
- Connessioni Società
